Any operation, indeed, any surgical intervention inevitably causes acute pain that usually subsides over time. However, persistent, chronic postsurgical pain may be severe in 2% to 10% of patients. As reviewed by Kehlet et al, 1 this discomfort generally lasts longer than 3 to 6 months after surgery. For example, thoracotomy has a 30% to 40% estimated incidence of chronic pain with a 10% incidence of severe, disabling pain.
Several factors are in play in the development of postsurgical pain including:
Nociceptive pain results from activation of high-threshold peripheral sensory neurons by intense chemical, mechanical, or thermal noxious stimuli. This pain is from the scalpel blade cutting through the skin. Inflammatory pain reflects the heightened pain sensitivity that occurs in response to tissue injury and inflammation. In the absence of any peripheral nerve damage, this pain drives acute postoperative pain until surgical healing occurs. If inflammation persists, however, so will the pain. Spontaneous pain in the damaged area, heat hyperalgesia, and throbbing pain are characteristics of postoperative inflammatory pain. Neuropathic pain arises from injury to nerves or to sensory transmitting systems in the spinal cord and brain. Sensory loss is the universal response to nerve damage although other responses can occur, including spontaneous pain, dysasthesia, and hypersensitivity such as allodynia. Spontaneous pain in the damaged area, cold allodynia, burning, and throbbing pain with motor and sensory losses in the damaged nerve area are often encountered in postoperative neuropathic pain.
Chronic postsurgical pain is similar to neuropathic pain. In surgical procedures associated with chronic pain, major nerves are involved in the surgical field and damage to these nerves is often a prerequisite for the development of postsurgical chronic pain. Extensive nerve damage is frequent in thoracotomies. The chronic postthoracotomy pain syndrome is defined as pain that recurs or persists along a thoracotomy incision for at least 2 months following surgery and can occur in more than 50% of cases according to Strebel and Ross. 2 Multiple etiologies leading to this chronic pain have been proposed, including poorly repositioned rib fractures, costochondritis, costochondral dislocation, intercostal neuroma, nerve entrapment, and local infection. Other neurological signs of nerve damage in the form of hypoesthesia have been noted following mastectomy, hernia repair, and mandibular osteotomy.
Many surgical patients present with signs of neurological damage but without pain. For instance, after mandibular osteotomy, only 10% of patients with severe nerve damage develop clinically significant neuropathic pain. Although nerve damage seems to be necessary for the development of most cases of chronic postsurgical pain, other factors may play a role, such as:
Genetic susceptibility. Sensitivity to nociceptive and clinical pain varies considerably between individuals. This inconsistency is recognized as an indication of differing inherited susceptibility both to the generation and experience of pain, as well as to the response to analgesics. With the complexity of neuropathic pain, several genes may contribute and a familial trait is difficult to identify although studies are ongoing to correlate single nucleotide polymorphisms in multiple candidate genes with the risk of developing postinjury neuropathic pain. Preceding pain. A previous pain experience correlates with the development of chronic neuropathic pain. Severe postherpetic neuralgia is often preceded by severe zoster pain. Similarly, an association is observed between the intensity of acute postoperative pain and the subsequent development of chronic pain after breast surgery, thoracotomy, and inguinal hernia repair. Psychosocial factors. Fear, past memories, expectation of pain, social environment, work, and levels of physical activity all affect the response to noxious stimuli. Preoperative anxiety is correlated with the postoperative pain experience.
Age and sex. With postherpetic neuralgia, increasing age is a risk factor whereas in postherniorrhaphy pain, older patients have a reduced risk of developing chronic pain. Women have higher postoperative pain than men.
Breast cancer in the United States occurs in 1 in 8 women, therefore, breast surgery be it lumpectomy or mastectomy are common procedures. Recently, Gartner et al 3 studied 3754 women aged 18 to 70 years in Denmark, who received surgery and adjuvant therapy for primary breast cancer between January 1, 2005 and December 31, 2006. A study questionnaire was sent to the women between January and April 2008. The goal of the study was to examine prevalence, associated factors, and severity of chronic pain and sensory disturbances after surgery for breast cancer using a national data bank managed by the Danish Breast Cancer Cooperative Group (DBCG). Surgical procedures included mastectomy or breast conserving surgery (lumpectomy), with either sentinel lymph node dissection or axillary lymph node dissection. Additional treatment included radiation therapy following breast conserving therapy or, in selected cases, following mastectomy and axillary lymph node dissection. Antiestrogen treatment as well as chemotherapy was given as dictated by the DBCG protocol.
The overall response rate to the questionnaire was 87%. The results showed that 47% of women treated for breast cancer experienced pain and 58% of women experienced sensory disturbances in the surgical area 1 to 3 years after the procedure. The pain in half the cases was reported as moderate to severe. Age less than 40 years was identified as an important determinant of persistent pain and sensory disturbances. Radiation therapy was also a significant risk factor for reporting pain. Women who underwent mastectomy reported slightly but significantly more severe pain than women undergoing breast conserving surgery. In addition to the intraoperative nerve injury, the authors speculated that other factors including those reviewed previously, that is, genetic susceptibility, psychosocial factors, and preceding pain syndromes, may be important compounding variables in the development of postsurgical chronic pain.
In the accompanying editorial, Loftus and Laronga 4 emphasize the importance of the clinical issue of chronic pain after breast surgery. In addition to the surgical nerve injury, the authors note that the following other etiologies should also be considered: brachial plexus infiltration by tumor; compression injury to the brachial plexus from lymphedema; radiation-induced ischemic plexopathy, injury, and fibrosis; carpal tunnel syndrome; second primary tumors.
Although postmastectomy and postthoracotomy chronic pain syndromes are well described and appreciated, other surgical procedures may also result in chronic pain 5 :
Postradical neck dissection pain due to impairment of the cervical nerves C2 through C6 when tissue-sparing procedures are not feasible. Postnephrectomy pain related to the damage to the branches of the L1 division of the lumbosaral plexus. Postamputation (phantom) pain.
Prevention of postsurgical neuropathic pain is related to the procedure and surgical technique. Early reports 1 suggest that preservation of the intercostal brachial nerve could decrease postmastectomy chronic pain. Also, the expanding use of the sentinel lymph node biopsy might reduce the need for axillary node dissection and thus limit intercostal nerve damage. Minimally invasive thorascopic techniques could spare the intercostal nerves as well as the use of an intracostal suture technique to avoid direct nerve compression with thoracotomies. Other minimally invasive surgical techniques are currently being explored with the goal of minimizing both acute and chronic postsurgical pain.
Pharmacologic management of postsurgical chronic neuropathic pain is beyond the scope of this editorial and the article by Shah and Moradimehr 6 in this issue is a helpful start.
In sum, acute postoperative pain is followed by chronic pain in 10% to 50% of patients after common operations. This pain can be severe in about 2% to 10% of patients and is often underrecognized. In a recent study of a large number of Danish women who underwent breast cancer treatment, persistent pain and sensory disturbances remained clinically significant some 2 to 3 years after treatment.
